Advanced Enzyme Technologies Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Advanced Enzyme Technologies announced that ICRA has rated the company's debt facilities of Rs 100 crore at ICRA AA-; Stable; ICRA A1+.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 12.88% to Rs 42.50 crore in the quarter ended December 2025 as against Rs 37.65 crore during the previous quarter ended December 2024. Sales rose 1.68% to Rs 171.95 crore in the quarter ended December 2025 as against Rs 169.11 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 31 January 2026.

Powered by Capital Market - Live News

Total expenditure for the period under review added up to Rs 135.27 crore, up 19.2% YoY. This was primarily due to higher raw material costs (up 24.8% YoY), higher employee expenses (up 10.8% YoY) and higher other expenses (up 14.3% YoY).

Profit before tax in Q2 FY26 stood at Rs 59.54 crore, up by 41% from Rs 42.21 crore recorded in Q2 FY25.

Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions.

Powered by Capital Market - Live News